Transfusion Medicine Reviews
Volume 17, Issue 2 , Pages 95-109 , April 2003

Islet transplantation, stem cells, and transfusion medicine

References 

  1. Kelly WD, Lillehei RC, Merkel FK, et al.  Allotransplantation of the pancreas and duodenum along with the kidney in diabetic nephropathy. Surgery. 1967;61:827–837
  2. Reach G. Islet transplantation: A field on the move. Nephrol Dial Transplant. 2001;16:893–896
  3. White SA, James RF, Swift SM, et al.  Human islet cell transplantation—Future prospects. Diabet Med. 2001;18:78–103
  4. Inoue K, Miyamoto M. Islet transplantation. J Hepatobiliary Pancreat Surg. 2000;7:163–177
  5. American Diabetes Association . Economic consequences of diabetes mellitus in the U.S. in 1997. Diabetes Care. 1998;21:296–309
  6. Atkinson MA, Eisenbarth GS. Type 1 diabetes: New perspectives on disease pathogenesis and treatment. Lancet. 2001;358:221–229
  7. Harris MI. Diabetes in America: Epidemiology and scope of the problem. Diabetes Care. 1998;21(suppl):C11–C14
  8. Mokdad AH, Ford ES, Bowman BA, et al.  Diabetes trends in the U.S.: 1990-1998. Diabetes Care. 2000;23:1278–1283
  9. Pratley RE, Weyer C. The role of impaired early insulin secretion in the pathogenesis of Type II diabetes mellitus. Diabetologia. 2001;44:929–945
  10. Cerasi E, Boitard C, Efendic S, et al.  The islet in type 2 diabetes: Back to center stage. Diabetes. 2001;50:S1–S3
  11. The Diabetes Control and Complications Trial Research Group . The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–986
  12. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group . Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med. 2000;342:381–389
  13. International Pancreas Transplant Registry. Available at http://www.iptr.umn.edu/June 1, 2002; Accessed
  14. Tyden G, Bolinder J, Solders G, et al.  Improved survival in patients with insulin-dependent diabetes mellitus and end-stage diabetic nephropathy 10 years after combined pancreas and kidney transplantation. Transplantation. 1999;67:645–648
  15. Fioretto P, Steffes MW, Sutherland DE, et al.  Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med. 1998;339:69–75
  16. Shapiro AM, Lakey JR, Ryan EA, et al.  Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med. 2000;343:230–238
  17. Internation Islet Transplant Registry. Available at http://www.med.uni-giessen.de/itr/June 1, 2002; Accessed
  18. Robertson RP, Lanz KJ, Sutherland DE, et al.  Prevention of diabetes for up to 13 years by autoislet transplantation after pancreatectomy for chronic pancreatitis. Diabetes. 2001;50:47–50
  19. Ryan EA, Lakey JR, Rajotte RV, et al.  Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes. 2001;50:710–719
  20. Hauptman PJ, O'Connor KJ. Procurement and allocation of solid organs for transplantation. N Engl J Med. 1997;336:422–431
  21. Lakey JR, Warnock GL, Rajotte RV, et al.  Variables in organ donors that affect the recovery of human islets of Langerhans. Transplantation. 1996;61:1047–1053
  22. Clayton HA, Swift SM, Turner JM, et al.  Non-heart-beating organ donors: A potential source of islets for transplantation?. Transplantation. 2000;69:2094–2098
  23. Ricordi C, Lacy PE, Finke EH, et al.  Automated method for isolation of human pancreatic islets. Diabetes. 1988;37:413–420
  24. Gill JF, Chambers LL, Baurley JL, et al.  Safety testing of Liberase, a purified enzyme blend for human islet isolation. Transplant Proc. 1995;27:3276–3277
  25. Lakey JR, Cavanagh TJ, Zieger MA, et al.  Evaluation of a purified enzyme blend for the recovery and in vitro function of isolated canine islets. Transplant Proc. 1998;30:590–591
  26. Linetsky E, Bottino R, Lehmann R, et al.  Improved human islet isolation using a new enzyme blend, Liberase. Diabetes. 1997;46:1120–1123
  27. Lakey JR, Helms LM, Kin T, et al.  Serine-protease inhibition during islet isolation increases islet yield from human pancreases with prolonged ischemia. Transplantation. 2001;72:565–570
  28. Gores PF, Sutherland DE. Pancreatic islet transplantation: Is purification necessary?. Am J Surg. 1993;166:538–542
  29. Brandhorst H, Brandhorst D, Brendel MD, et al.  Monitoring of insulin content during human islet isolation. Transplant Proc. 1998;30:364–365
  30. Robertson GS, Chadwick DR, Contractor H, et al.  The use of continuous density gradients for the assessment of islet and exocrine tissue densities and islet purification. Acta Diabetol. 1993;30:175–180
  31. Lake SP, Bassett PD, Larkins A, et al.  Large-scale purification of human islets utilizing discontinuous albumin gradient on IBM 2991 cell separator. Diabetes. 1989;38:143–145 (suppl)
  32. Weir GC, Bonner-Weir S, Leahy JL. Islet mass and function in diabetes and transplantation. Diabetes. 1990;39:401–405
  33. Saito K, Iwama N, Takahashi T. Morphometrical analysis on topographical difference in size distribution, number and volume of islets in the human pancreas. Tohoku J Exp Med. 1978;124:177–186
  34. Scharp DW, Lacy PE, McLear M, et al.  The bioburden of 590 consecutive human pancreata for islet transplant research. Transplant Proc. 1992;24:974–975
  35. Warnock GL, Kneteman NM, Ryan E, et al.  Normoglycaemia after transplantation of freshly isolated and cryopreserved pancreatic islets in type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 1991;34:55–58
  36. Warnock GL, Kneteman NM, Ryan EA, et al.  Long-term follow-up after transplantation of insulin-producing pancreatic islets into patients with type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 1992;35:89–95
  37. Evans MG, Rajotte RV, Warnock GL, et al.  Cryopreservation purifies canine pancreatic microfragments. Transplant Proc. 1987;19:3471–3477
  38. Cattral MS, Warnock GL, Kneteman NM, et al.  The effect of cryopreservation on the survival and MHC antigen expression of murine islet allografts. Transplantation. 1993;55:159–163
  39. Cattral MS, Lakey JR, Warnock GL, et al.  Effect of cryopreservation on the survival and function of murine islet isografts and allografts. Cell Transplant. 1998;7:373–379
  40. Rajotte RV, Warnock GL, Kneteman NN. Cryopreservation of insulin-producing tissue in rats and dogs. World J Surg. 1984;8:179–186
  41. Warnock GL, Gray DW, McShane P, et al.  Survival of cryopreserved isolated adult human pancreatic islets of Langerhans. Transplantation. 1987;44:75–82
  42. Kneteman NM, Alderson D, Scharp DW, et al.  Long-term cryogenic storage of purified adult human islets of Langerhans. Diabetes. 1989;38:386–396
  43. Piemonti L, Bertuzzi F, Nano R, et al.  Effects of cryopreservation on in vitro and in vivo long-term function of human islets. Transplantation. 1999;68:655–662
  44. Fahy GM, MacFarlane DR, Angell CA, et al.  Vitrification as an approach to cryopreservation. Cryobiology. 1984;21:407–426
  45. Langer S, Lau D, Eckhardt T, et al.  Viability and recovery of frozen-thawed human islets and in vivo quality control by xenotransplantation. J Mol Med. 1999;77:172–174
  46. Miyamoto M, Balamurugan AN, Nozawa Y, et al.  Development of a cryopreservation procedure employing a freezer bag for pancreatic islets using a newly developed cryoprotectant. Cell Transplant. 2001;10:363–371
  47. Lakey JR, Anderson TJ, Rajotte RV. Novel approaches to cryopreservation of human pancreatic islets. Transplantation. 2001;72:1005–1011
  48. Lakey JR, Rajotte RV, Fedorow CA, et al.  Islet cryopreservation using intracellular preservation solutions. Cell Transplant. 2001;10:583–589
  49. Swift SM, Thirdborough SM, London NJ, et al.  Human islet preparations and the expression of MHC antigens. Transplant Proc. 1992;24:1029
  50. Stock PG, Ascher NL, Chen S, et al.  Evidence for direct and indirect pathways in the generation of the alloimmune response against pancreatic islets. Transplantation. 1991;52:704–709
  51. Tamura K, Fujimura T, Tsutsumi T, et al.  Transcriptional inhibition of insulin by FK506 and possible involvement of FK506 binding protein-12 in pancreatic beta-cell. Transplantation. 1995;59:1606–1613
  52. Ryu S, Kodama S, Ryu K, et al.  Reversal of established autoimmune diabetes by restoration of endogenous beta cell function. J Clin Invest. 2001;108:63–72
  53. Chatenoud L. Restoration of self-tolerance is a feasible approach to control ongoing beta-cell specific autoreactivity: Its relevance for treatment in established diabetes and islet transplantation. Diabetologia. 2001;44:521–536
  54. Smith RM, Mandel TE. Pancreatic islet xenotransplantation: The potential for tolerance induction. Immunol Today. 2000;21:42–48
  55. Bonner-Weir S. Beta-cell turnover: Its assessment and implications. Diabetes. 2001;50:S20–S24 (suppl)
  56. Anastasi E, Ponte E, Gradini R, et al.  Expression of Reg and cytokeratin 20 during ductal cell differentiation and proliferation in a mouse model of autoimmune diabetes. Eur J Endocrinol. 1999;141:644–652
  57. Okamoto H. The Reg gene family and Reg proteins: With special attention to the regeneration of pancreatic beta-cells. J Hepatobiliary Pancreat Surg. 1999;6:254–262
  58. Hardikar AA, Karandikar MS, Bhonde RR. Effect of partial pancreatectomy on diabetic status in BALB/c mice. J Endocrinol. 1999;162:189–195
  59. Kritzik MR, Krahl T, Good A, et al.  Transcription factor expression during pancreatic islet regeneration. Mol Cell Endocrinol. 2000;164:99–107
  60. Al-Abdullah IH, Ayala T, Panigrahi D, et al.  Neogenesis of pancreatic endocrine cells in copper-deprived rat models. Pancreas. 2000;21:63–68
  61. Del Zotto H, Massa L, Rafaeloff R, et al.  Possible relationship between changes in islet neogenesis and islet neogenesis-associated protein-positive cell mass induced by sucrose administration to normal hamsters. J Endocrinol. 2000;165:725–733
  62. Edlund H. Factors controlling pancreatic cell differentiation and function. Diabetologia. 2001;44:1071–1079
  63. McKinnon CM, Docherty K. Pancreatic duodenal homeobox-1, PDX-1, a major regulator of beta cell identity and function. Diabetologia. 2001;44:1203–1214
  64. Li L, Seno M, Yamada H, et al.  Promotion of beta-cell regeneration by betacellulin in ninety percent- pancreatectomized rats. Endocrinology. 2001;142:5379–5385
  65. Kaido T, Imamura M. Hepatocyte growth factor: Clinical implications in hepatobiliary pancreatic surgery. J Hepatobiliary Pancreat Surg. 2001;8:65–75
  66. Bonner-Weir S, Taneja M, Weir GC, et al.  In vitro cultivation of human islets from expanded ductal tissue. Proc Natl Acad Sci U S A. 2000;97:7999–8004
  67. Ramiya VK, Maraist M, Arfors KE, et al.  Reversal of insulin-dependent diabetes using islets generated in vitro from pancreatic stem cells. Nat Med. 2000;6:278–282
  68. Gmyr V, Kerr-Conte J, Vandewalle B, et al.  Human pancreatic ductal cells: Large-scale isolation and expansion. Cell Transplant. 2001;10:109–121
  69. Zulewski H, Abraham EJ, Gerlach MJ, et al.  Multipotential nestin-positive stem cells isolated from adult pancreatic islets differentiate ex vivo into pancreatic endocrine, exocrine, and hepatic phenotypes. Diabetes. 2001;50:521–533
  70. Assady S, Maor G, Amit M, et al.  Insulin production by human embryonic stem cells. Diabetes. 2001;50:1691–1697
  71. Lumelsky N, Blondel O, Laeng P, et al.  Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science. 2001;292:1389–1394
  72. Soria B, Roche E, Berna G, et al.  Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice. Diabetes. 2000;49:157–162
  73. Anderson DJ, Gage FH, Weissman IL. Can stem cells cross lineage boundaries?. Nat Med. 2001;7:393–395
  74. Theise ND, Krause DS. Toward a new paradigm of cell plasticity. Leukemia. 2002;16:542–548
  75. Wulf GG, Jackson KA, Goodell MA. Somatic stem cell plasticity: Current evidence and emerging concepts. Exp Hematol. 2001;29:1361–1370
  76. Almeida-Porada G, Porada C, Zanjani ED. Adult stem cell plasticity and methods of detection. Rev Clin Exp Hematol. 2001;5:26–41
  77. Jackson KA, Majka SM, Wulf GG, et al.  Stem cells: A minireview. J Cell Biochem Suppl. 2002;38:1–6
  78. Hawley RG, Sobieski DA. Somatic stem cell plasticity: to be or not to be. Stem Cells. 2002;20:195–197
  79. Petersen BE, Bowen WC, Patrene KD, et al.  Bone marrow as a potential source of hepatic oval cells. Science. 1999;284:1168–1170
  80. Theise ND, Badve S, Saxena R, et al.  Derivation of hepatocytes from bone marrow cells in mice after radiation-induced myeloablation. Hepatology. 2000;31:235–240
  81. Theise ND, Nimmakayalu M, Gardner R, et al.  Liver from bone marrow in humans. Hepatology. 2000;32:11–16
  82. Lagasse E, Connors H, Al-Dhalimy M, et al.  Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med. 2000;6:1229–1234
  83. Alison MR, Poulsom R, Jeffery R, et al.  Hepatocytes from non-hepatic adult stem cells. Nature. 2000;406:257
  84. Korbling M, Katz RL, Khanna A, et al.  Hepatocytes and epithelial cells of donor origin in recipients of peripheral-blood stem cells. N Engl J Med. 2002;346:738–746
  85. Ferrari G, Cusella-De Angelis G, Coletta M, et al.  Muscle regeneration by bone marrow-derived myogenic progenitors. Science. 1998;279:1528–1530
  86. Gussoni E, Soneoka Y, Strickland CD, et al.  Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature. 1999;401:390–394
  87. Bittner RE, Schofer C, Weipoltshammer K, et al.  Recruitment of bone-marrow-derived cells by skeletal and cardiac muscle in adult dystrophic mdx mice. Anat Embryol (Berl). 1999;199:391–396
  88. Jackson KA, Mi T, Goodell MA. Hematopoietic potential of stem cells isolated from murine skeletal muscle. Proc Natl Acad Sci U S A. 1999;96:14482–14486
  89. Jackson KA, Majka SM, Wang H, et al.  Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest. 2001;107:1395–1402
  90. Orlic D, Kajstura J, Chimenti S, et al.  Bone marrow cells regenerate infarcted myocardium. Nature. 2001;410:701–705
  91. Orlic D, Kajstura J, Chimenti S, et al.  Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci U S A. 2001;98:10344–10349
  92. Asahara T, Masuda H, Takahashi T, et al.  Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res. 1999;85:221–228
  93. Kocher AA, Schuster MD, Szabolcs MJ, et al.  Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med. 2001;7:430–436
  94. Krause DS, Theise ND, Collector MI, et al.  Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell. 2001;105:369–377
  95. Brazelton TR, Rossi FM, Keshet GI, et al.  From marrow to brain: Expression of neuronal phenotypes in adult mice. Science. 2000;290:1775–1779
  96. Mezey E, Chandross KJ, Harta G, et al.  Turning blood into brain: Cells bearing neuronal antigens generated in vivo from bone marrow. Science. 2000;290:1779–1782
  97. Woodbury D, Schwarz EJ, Prockop DJ, et al.  Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res. 2000;61:364–370
  98. Poulsom R, Forbes SJ, Hodivala-Dilke K, et al.  Bone marrow contributes to renal parenchymal turnover and regeneration. J Pathol. 2001;195:229–235
  99. Quaini F, Urbanek K, Beltrami AP, et al.  Chimerism of the transplanted heart. N Engl J Med. 2002;346:5–15
  100. Laflamme MA, Myerson D, Saffitz JE, et al.  Evidence for cardiomyocyte repopulation by extracardiac progenitors in transplanted human hearts. Circ Res. 2002;90:634–640
  101. Jiang Y, Jahagirdar BN, Reinhardt RL, et al.  Pluripotency of mesenchymal stem cells derived from adult marrow. Nature. 2002;418:41–49
  102. McKinney-Freeman SL, Jackson KA, Camargo FD, et al.  Muscle-derived hematopoietic stem cells are hematopoietic in origin. Proc Natl Acad Sci U S A. 2002;99:1341–1346
  103. Deutsch G, Jung J, Zheng M, et al.  A bipotential precursor population for pancreas and liver within the embryonic endoderm. Development. 2001;128:871–881
  104. Wang X, Al-Dhalimy M, Lagasse E, et al.  Liver repopulation and correction of metabolic liver disease by transplanted adult mouse pancreatic cells. Am J Pathol. 2001;158:571–579
  105. Yang L, Li S, Hatch H, et al.  In vitro trans-differentiation of adult hepatic stem cells into pancreatic endocrine hormone-producing cells. Proc Natl Acad Sci U S A. 2002;99:8078–8083
  106. Levine F, Leibowitz G. Towards gene therapy of diabetes mellitus. Mol Med Today. 1999;5:165–171
  107. Efrat S. Prospects for gene therapy of insulin-dependent diabetes mellitus. Diabetologia. 1998;41:1401–1409
  108. Lee HC, Kim SJ, Kim KS, et al.  Remission in models of type 1 diabetes by gene therapy using a single-chain insulin analogue. Nature. 2000;408:483–488
  109. Thule PM, Liu JM. Regulated hepatic insulin gene therapy of STZ-diabetic rats. Gene Ther. 2000;7:1744–1752
  110. Thule PM, Liu J, Phillips LS. Glucose regulated production of human insulin in rat hepatocytes. Gene Ther. 2000;7:205–214
  111. Boker A, Rothenberg L, Hernandez C, et al.  Human islet transplantation: update. World J Surg. 2001;25:481–486
  112. Bach FH, Robson SC, Ferran C, et al.  Endothelial cell activation and thromboregulation during xenograft rejection. Immunol Rev. 1994;141:5–30
  113. Brandhorst H, Brandhorst D, Hering BJ, et al.  Significant progress in porcine islet mass isolation utilizing liberase HI for enzymatic low-temperature pancreas digestion. Transplantation. 1999;68:355–361
  114. Diamond LE, Quinn CM, Martin MJ, et al.  A human CD46 transgenic pig model system for the study of discordant xenotransplantation. Transplantation. 2001;71:132–142
  115. Groth CG, Korsgren O, Tibell A, et al.  Transplantation of porcine fetal pancreas to diabetic patients. Lancet. 1994;344:1402–1404
  116. Krook H, Hagberg A, Song Z, et al.  A distinct Th1 immune response precedes the described Th2 response in islet xenograft rejection. Diabetes. 2002;51:79–86
  117. Moses RD, Winn HJ, Auchincloss H. Evidence that multiple defects in cell-surface molecule interactions across species differences are responsible for diminished xenogeneic T cell responses. Transplantation. 1992;53:203–209
  118. Bretzel RG, Flesch BK, Hering BJ, et al.  Impact of culture and cryopreservation on MHC class II antigen expression in canine and porcine islets. Horm Metab Res Suppl. 1990;25:128–132
  119. Parr EL, Bowen KM, Lafferty KJ. Cellular changes in cultured mouse thyroid glands and islets of Langerhans. Transplantation. 1980;30:135–141
  120. Bach FH, Fineberg HV. Call for moratorium on xenotransplants. Nature. 1998;391:326
  121. Heneine W, Tibell A, Switzer WM, et al.  No evidence of infection with porcine endogenous retrovirus in recipients of porcine islet-cell xenografts. Lancet. 1998;352:695–699
  122. Paradis K, Langford G, Long Z, et al.  Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue. The XEN 111 Study Group. Science. 1999;285:1236–1241
  123. Shapiro AM, Lakey JR. Future trends in islet cell transplantation. Diabetes Technol Ther. 2002;2:449–452
  124. Kenyon NS, Chatzipetrou M, Masetti M, et al.  Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154. Proc Natl Acad Sci U S A. 1999;96:8132–8137
  125. Kenyon NS, Fernandez LA, Lehmann R, et al.  Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154. Diabetes. 1999;48:1473–1481
  126. Ildstad ST, Sachs DH. Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature. 1984;307:168–170
  127. Nikolic B, Sykes M. Mixed hematopoietic chimerism and transplantation tolerance. Immunol Res. 1997;16:217–228
  128. Wekerle T, Sykes M. Mixed chimerism as an approach for the induction of transplantation tolerance. Transplantation. 1999;68:459–467
  129. Sykes M, Szot GL, Swenson KA, et al.  Induction of high levels of allogeneic hematopoietic reconstitution and donor-specific tolerance without myelosuppressive conditioning. Nat Med. 1997;3:783–787
  130. Wekerle T, Sayegh MH, Ito H, et al.  Anti-CD154 or CTLA4Ig obviates the need for thymic irradiation in a non-myeloablative conditioning regimen for the induction of mixed hematopoietic chimerism and tolerance. Transplantation. 1999;68:1348–1355
  131. Kawai T, Sogawa H, Koulmanda M, et al.  Long-term islet allograft function in the absence of chronic immunosuppression: A case report of a nonhuman primate previously made tolerant to a renal allograft from the same donor. Transplantation. 2001;72:351–354
  132. de Vos P, Hamel AF, Tatarkiewicz K. Considerations for successful transplantation of encapsulated pancreatic islets. Diabetologia. 2002;45:159–173
  133. Wang W, Gu Y, Tabata Y, et al.  Reversal of diabetes in mice by xenotransplantation of a bioartificial pancreas in a prevascularized subcutaneous site. Transplantation. 2002;73:122–129
  134. Sun Y, Ma X, Zhou D, et al.  Normalization of diabetes in spontaneously diabetic cynomologus monkeys by xenografts of microencapsulated porcine islets without immunosuppression. J Clin Invest. 1996;98:1417–1422
  135. Weber CJ, Hagler M, Konieczny B, et al.  Encapsulated islet iso-, allo-, and xenografts in diabetic NOD mice. Transplant Proc. 1995;27:3308–3311
  136. Lanza RP, Chick WL. Immunoisolation: at a turning point. Immunol Today. 1997;18:135–139
  137. Weber CJ, Zabinski S, Koschitzky T, et al.  The role of CD4+ helper T cells in the destruction of microencapsulated islet xenografts in nod mice. Transplantation. 1990;49:396–404
  138. Kulseng B, Thu B, Espevik T, et al.  Alginate polylysine microcapsules as immune barrier: Permeability of cytokines and immunoglobulins over the capsule membrane. Cell Transplant. 1997;6:387–394
  139. De Vos P, De Haan BJ, Wolters GH, et al.  Improved biocompatibility but limited graft survival after purification of alginate for microencapsulation of pancreatic islets. Diabetologia. 1997;40:262–270
  140. Lacy PE, Finke EH. Activation of intraislet lymphoid cells causes destruction of islet cells. Am J Pathol. 1991;138:1183–1190
  141. Stegall MD, Tezuka K, Oluwole SF, et al.  Interstitial class II-positive cell depletion by donor pretreatment with gamma irradiation. Evidence of differential immunogenicity between vascularized cardiac allografts and islets. Transplantation. 1990;49:246–251
  142. James RF, Lake SP, Chamberlain J, et al.  Long-term survival of rat islet allografts after pretreatment with low dose gamma irradiation. Transplant Proc. 1989;21:2725–2726
  143. Hugues S, Mougneau E, Ferlin W, et al.  Tolerance to islet antigens and prevention from diabetes induced by limited apoptosis of pancreatic beta cells. Immunity. 2002;16:169–181

☆ Address reprint requests to Lennart Lögdberg, MD, PhD, Transfusion Medicine Program, Department of Pathology and Laboratory Medicine, Emory University, 1364 Clifton Road NE, Atlanta, GA 30322. E-mail: llogdbe@emory.edu.

☆☆ 0887-7963/03/1702-0002$30.00/0

PII: S0887-7963(03)90001-0

doi: 10.1016/S0887-7963(03)90001-0

Transfusion Medicine Reviews
Volume 17, Issue 2 , Pages 95-109 , April 2003

Article Tools

* Image Usage & Resolution